NCT01820143View on ClinicalTrials.gov

Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
HealthyPharmacokineticsPharmacodynamicsIlaprazole
Interventions
DRUG

Ilaprazole

DRUG

Esomeprazole

Trial Locations (1)

Unknown

MDS Pharma Services, Québec

All Listed Sponsors
lead

Il-Yang Pharm. Co., Ltd.

INDUSTRY

NCT01820143 - Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety | Biotech Hunter | Biotech Hunter